. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA. 2003 Apr 23-30;289(16):2094-103. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ1-42
(CSF)
AD
(131)
183 ± 121
pg/mL
ELISA;
Other/Not Specified;
In-house
DSM-IV, 1993; McKhann et al., 1984
Aβ1-42
(CSF)
CTRL-
CNC
(72)
491 ± 245
pg/mL
ELISA;
Other/Not Specified;
In-house
tau-total
(CSF)
AD
(131)
587 ± 365
pg/mL
ELISA;
Innotest;
Innogenetics
DSM-IV, 1993; McKhann et al., 1984
tau-total
(CSF)
CTRL-
CNC
(72)
224 ± 156
pg/mL
ELISA;
Innotest;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.